Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026?
Health & MedicineOne-Off3MonManifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseNein 92.9%
Prognostiker
4
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 7 Stunden
Veraltet5. Sept. 23, 09:52 UTC31. Dez. 26, 22:59 UTC
Trends
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
When will Tesla Cybertruck be available in Europe?
Manifold MarketsWill the FDA approve any psychedelic substance for medical use this year?
KalshiWill Drift0r's medical problem be found before 2027?
Manifold MarketsWhat will be true of the explosion at Harvard Medical School?
Manifold MarketsHantavirus pandemic in 2026?
PolymarketMeasles cases in 2026?
KalshiRegeln
The clinical trials for fat tissue regrowing implants have already started in France and Spain.
- It is projected to finish in 2025.
- And it will change the silicon paradigm in plastic surgery.
- Will this technology be available for reconstructive or aesthetic breast surgery by the end of 2026 outside of clinical trials?
- https://www.theguardian.com/society/2022/jul/03/breast-reconstruction-cancer-silicone-implants-regrowing
- [link preview]
Offene Märkte
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No+0.4pt97%
- Yes-0.4pt3%
- Gesamtvolumen
- 15,7 Mio. €
- 24h-Volumen
- 52.229,8 €
KALSHIMeasles cases in 2026?
- Above 4000+2.0pt99%
- Above 300099%
- Above 600061%
+2 weitere Ergebnisse
- Gesamtvolumen
- 870.445,2 €
- 24h-Volumen
- 2087,6 €
POLYMARKETNew pandemic in 2026?
- No-1.0pt93.1%
- Yes+1.0pt6.9%
- Gesamtvolumen
- 922.473,3 €
- 24h-Volumen
- 1758,2 €
KALSHICyclosporiasis cases reported in the US in 2026?
- Above 18k99%
- Above 6k99%
- Above 10k99%
+12 weitere Ergebnisse
- Gesamtvolumen
- 32.412,1 €
- 24h-Volumen
- 1299,1 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes+0.4pt3%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 933,9 €
KALSHIHealthcare AI adoption in September
- Above 43%87%
- Above 43.75%59%
- Above 45%14%
+4 weitere Ergebnisse
- Gesamtvolumen
- 810,1 €
- 24h-Volumen
- 767 €
- FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- Measles cases in U.S. by September 30?
- What will the average number of measles cases be during Trump's term?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Will the FDA approve any psychedelic substance for medical use this year?
- Pandemic in 2026?
- How many human screwworm cases will be reported in the United States in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- Which countries will have an Ebola case in 2026?
- Ebola: new country confirmed before October 1?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026??
- Manifold Markets bewertet No mit 93% (Stand: 11. September 2026).
- Wann wird Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026? entschieden?
- Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026? soll am 31. Dezember 2026 entschieden werden.
- Wie wird Will Lattice Medical new bioengineered breast-growing implants be available in Europe by the end of 2026? abgerechnet?
- Manifold Markets rechnet diesen Markt wie folgt ab: The clinical trials for fat tissue regrowing implants have already started in France and Spain.